<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-04-22" version="187">
<accession>P55085</accession>
<accession>Q13317</accession>
<accession>Q13346</accession>
<accession>Q53XJ8</accession>
<name>PAR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Proteinase-activated receptor 2</fullName>
<shortName>PAR-2</shortName>
</recommendedName>
<alternativeName>
<fullName>Coagulation factor II receptor-like 1</fullName>
</alternativeName>
<alternativeName>
<fullName>G-protein coupled receptor 11</fullName>
</alternativeName>
<alternativeName>
<fullName>Thrombin receptor-like 1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Proteinase-activated receptor 2, alternate cleaved 1</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Proteinase-activated receptor 2, alternate cleaved 2</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">F2RL1</name>
<name type="synonym">GPR11</name>
<name type="synonym">PAR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Eur. J. Biochem." volume="232" first="84" last="89">
<title>Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.</title>
<authorList>
<person name="Nystedt S."/>
<person name="Emilsson K."/>
<person name="Larsson A.-K."/>
<person name="Stroembeck B."/>
<person name="Sundelin J."/>
</authorList>
<dbReference type="PubMed" id="7556175"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1995.tb20784.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Biochem. J." volume="314" first="1009" last="1016">
<title>Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2.</title>
<authorList>
<person name="Boehm S.K."/>
<person name="Kong W."/>
<person name="Broemme D."/>
<person name="Smeekens S.P."/>
<person name="Anderson D.C."/>
<person name="Connolly A.J."/>
<person name="Kahn M.L."/>
<person name="Nelken N.A."/>
<person name="Coughlin S.R."/>
<person name="Payan D.G."/>
<person name="Bunnett N.W."/>
</authorList>
<dbReference type="PubMed" id="8615752"/>
<dbReference type="DOI" id="10.1042/bj3141009"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="7927" last="7936">
<title>Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1.</title>
<authorList>
<person name="Luo W."/>
<person name="Wang Y."/>
<person name="Hanck T."/>
<person name="Stricker R."/>
<person name="Reiser G."/>
</authorList>
<dbReference type="PubMed" id="16410250"/>
<dbReference type="DOI" id="10.1074/jbc.m510784200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH COPS5</scope>
</reference>
<reference key="4">
<citation type="submission" date="2001-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS PHE-21; GLN-270 AND ALA-291</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Ovary</tissue>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Mol. Med." volume="2" first="349" last="357">
<title>Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.</title>
<authorList>
<person name="Kahn M.L."/>
<person name="Ishii K."/>
<person name="Kuo W.L."/>
<person name="Piper M."/>
<person name="Connolly A.J."/>
<person name="Shi Y.P."/>
<person name="Wu R."/>
<person name="Lin C.C."/>
<person name="Coughlin S.R."/>
</authorList>
<dbReference type="PubMed" id="8784787"/>
<dbReference type="DOI" id="10.1007/bf03401632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-397</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="4043" last="4049">
<title>Interactions of mast cell tryptase with thrombin receptors and PAR-2.</title>
<authorList>
<person name="Molino M."/>
<person name="Barnathan E.S."/>
<person name="Numerof R."/>
<person name="Clark J."/>
<person name="Dreyer M."/>
<person name="Cumashi A."/>
<person name="Hoxie J.A."/>
<person name="Schechter N."/>
<person name="Woolkalis M."/>
<person name="Brass L.F."/>
</authorList>
<dbReference type="PubMed" id="9020112"/>
<dbReference type="DOI" id="10.1074/jbc.272.7.4043"/>
</citation>
<scope>ACTIVATION BY MAST CELL TRYPTASE</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Nature" volume="398" first="156" last="160">
<title>A protective role for protease-activated receptors in the airways.</title>
<authorList>
<person name="Cocks T.M."/>
<person name="Fong B."/>
<person name="Chow J.M."/>
<person name="Anderson G.P."/>
<person name="Frauman A.G."/>
<person name="Goldie R.G."/>
<person name="Henry P.J."/>
<person name="Carr M.J."/>
<person name="Hamilton J.R."/>
<person name="Moffatt J.D."/>
</authorList>
<dbReference type="PubMed" id="10086357"/>
<dbReference type="DOI" id="10.1038/18223"/>
</citation>
<scope>FUNCTION IN EPITHELIAL BARRIER PROTECTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="13502" last="13509">
<title>Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.</title>
<authorList>
<person name="O'Brien P.J."/>
<person name="Prevost N."/>
<person name="Molino M."/>
<person name="Hollinger M.K."/>
<person name="Woolkalis M.J."/>
<person name="Woulfe D.S."/>
<person name="Brass L.F."/>
</authorList>
<dbReference type="PubMed" id="10788464"/>
<dbReference type="DOI" id="10.1074/jbc.275.18.13502"/>
</citation>
<scope>TRANSACTIVATION BY F2R</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Cell Biol." volume="148" first="1267" last="1281">
<title>beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.</title>
<authorList>
<person name="DeFea K.A."/>
<person name="Zalevsky J."/>
<person name="Thoma M.S."/>
<person name="Dery O."/>
<person name="Mullins R.D."/>
<person name="Bunnett N.W."/>
</authorList>
<dbReference type="PubMed" id="10725339"/>
<dbReference type="DOI" id="10.1083/jcb.148.6.1267"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF SER-363 AND THR-366</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="26333" last="26342">
<title>Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates.</title>
<authorList>
<person name="Takeuchi T."/>
<person name="Harris J.L."/>
<person name="Huang W."/>
<person name="Yan K.W."/>
<person name="Coughlin S.R."/>
<person name="Craik C.S."/>
</authorList>
<dbReference type="PubMed" id="10831593"/>
<dbReference type="DOI" id="10.1074/jbc.m002941200"/>
</citation>
<scope>ACTIVATION BY ST14</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="5255" last="5260">
<title>Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.</title>
<authorList>
<person name="Camerer E."/>
<person name="Huang W."/>
<person name="Coughlin S.R."/>
</authorList>
<dbReference type="PubMed" id="10805786"/>
<dbReference type="DOI" id="10.1073/pnas.97.10.5255"/>
</citation>
<scope>ACTIVATION BY COAGULATION FACTORS VII AND XA</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Infect. Immun." volume="69" first="5121" last="5130">
<title>Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.</title>
<authorList>
<person name="Lourbakos A."/>
<person name="Potempa J."/>
<person name="Travis J."/>
<person name="D'Andrea M.R."/>
<person name="Andrade-Gordon P."/>
<person name="Santulli R."/>
<person name="Mackie E.J."/>
<person name="Pike R.N."/>
</authorList>
<dbReference type="PubMed" id="11447194"/>
<dbReference type="DOI" id="10.1128/iai.69.8.5121-5130.2001"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY GINGIPAINS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="31657" last="31666">
<title>Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes.</title>
<authorList>
<person name="Kanke T."/>
<person name="Macfarlane S.R."/>
<person name="Seatter M.J."/>
<person name="Davenport E."/>
<person name="Paul A."/>
<person name="McKenzie R.C."/>
<person name="Plevin R."/>
</authorList>
<dbReference type="PubMed" id="11413129"/>
<dbReference type="DOI" id="10.1074/jbc.m100377200"/>
</citation>
<scope>FUNCTION IN JNK AND NF-KAPPA-B PATHWAYS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="1014" last="1021">
<title>Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells.</title>
<authorList>
<person name="Sun G."/>
<person name="Stacey M.A."/>
<person name="Schmidt M."/>
<person name="Mori L."/>
<person name="Mattoli S."/>
</authorList>
<dbReference type="PubMed" id="11441110"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.2.1014"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY DUST MITE ALLERGENS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Immunol." volume="167" first="6615" last="6622">
<title>Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.</title>
<authorList>
<person name="Miike S."/>
<person name="McWilliam A.S."/>
<person name="Kita H."/>
</authorList>
<dbReference type="PubMed" id="11714832"/>
<dbReference type="DOI" id="10.4049/jimmunol.167.11.6615"/>
</citation>
<scope>FUNCTION IN INFLAMMATORY RESPONSE</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="Biochem. J." volume="368" first="495" last="505">
<title>Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.</title>
<authorList>
<person name="Compton S.J."/>
<person name="Sandhu S."/>
<person name="Wijesuriya S.J."/>
<person name="Hollenberg M.D."/>
</authorList>
<dbReference type="PubMed" id="12171601"/>
<dbReference type="DOI" id="10.1042/bj20020706"/>
</citation>
<scope>GLYCOSYLATION AT ASN-30 AND ASN-222</scope>
<scope>MUTAGENESIS OF ASN-30 AND ASN-222</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Jpn. J. Pharmacol." volume="88" first="77" last="84">
<title>Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear.</title>
<authorList>
<person name="Kawagoe J."/>
<person name="Takizawa T."/>
<person name="Matsumoto J."/>
<person name="Tamiya M."/>
<person name="Meek S.E."/>
<person name="Smith A.J."/>
<person name="Hunter G.D."/>
<person name="Plevin R."/>
<person name="Saito N."/>
<person name="Kanke T."/>
<person name="Fujii M."/>
<person name="Wada Y."/>
</authorList>
<dbReference type="PubMed" id="11859856"/>
<dbReference type="DOI" id="10.1254/jjp.88.77"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN ALLERGIC DERMATITIS</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Am. J. Respir. Cell Mol. Biol." volume="28" first="339" last="346">
<title>Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases.</title>
<authorList>
<person name="Dulon S."/>
<person name="Cande C."/>
<person name="Bunnett N.W."/>
<person name="Hollenberg M.D."/>
<person name="Chignard M."/>
<person name="Pidard D."/>
</authorList>
<dbReference type="PubMed" id="12594060"/>
<dbReference type="DOI" id="10.1165/rcmb.4908"/>
</citation>
<scope>DEACTIVATION BY NEUTROPHIL ELASTASE AND CATHEPSIN G</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="FASEB J." volume="17" first="1871" last="1885">
<title>Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo.</title>
<authorList>
<person name="Seeliger S."/>
<person name="Derian C.K."/>
<person name="Vergnolle N."/>
<person name="Bunnett N.W."/>
<person name="Nawroth R."/>
<person name="Schmelz M."/>
<person name="Von Der Weid P.Y."/>
<person name="Buddenkotte J."/>
<person name="Sunderkotter C."/>
<person name="Metze D."/>
<person name="Andrade-Gordon P."/>
<person name="Harms E."/>
<person name="Vestweber D."/>
<person name="Luger T.A."/>
<person name="Steinhoff M."/>
</authorList>
<dbReference type="PubMed" id="14519665"/>
<dbReference type="DOI" id="10.1096/fj.02-1112com"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN SKIN DISEASES</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Leukoc. Biol." volume="74" first="60" last="68">
<title>Expression of and functional responses to protease-activated receptors on human eosinophils.</title>
<authorList>
<person name="Bolton S.J."/>
<person name="McNulty C.A."/>
<person name="Thomas R.J."/>
<person name="Hewitt C.R."/>
<person name="Wardlaw A.J."/>
</authorList>
<dbReference type="PubMed" id="12832443"/>
<dbReference type="DOI" id="10.1189/jlb.0702351"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Cell. Signal." volume="16" first="21" last="29">
<title>The role of the C-terminal tail in protease-activated receptor-2-mediated Ca2+ signalling, proline-rich tyrosine kinase-2 activation, and mitogen-activated protein kinase activity.</title>
<authorList>
<person name="Seatter M.J."/>
<person name="Drummond R."/>
<person name="Kanke T."/>
<person name="Macfarlane S.R."/>
<person name="Hollenberg M.D."/>
<person name="Plevin R."/>
</authorList>
<dbReference type="PubMed" id="14607272"/>
<dbReference type="DOI" id="10.1016/s0898-6568(03)00095-0"/>
</citation>
<scope>MUTAGENESIS OF 355-ALA--SER-363</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="J. Leukoc. Biol." volume="76" first="388" last="398">
<title>Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices.</title>
<authorList>
<person name="Shpacovitch V.M."/>
<person name="Varga G."/>
<person name="Strey A."/>
<person name="Gunzer M."/>
<person name="Mooren F."/>
<person name="Buddenkotte J."/>
<person name="Vergnolle N."/>
<person name="Sommerhoff C.P."/>
<person name="Grabbe S."/>
<person name="Gerke V."/>
<person name="Homey B."/>
<person name="Hollenberg M."/>
<person name="Luger T.A."/>
<person name="Steinhoff M."/>
</authorList>
<dbReference type="PubMed" id="15155775"/>
<dbReference type="DOI" id="10.1189/jlb.0503221"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="16076" last="16087">
<title>c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2.</title>
<authorList>
<person name="Jacob C."/>
<person name="Cottrell G.S."/>
<person name="Gehringer D."/>
<person name="Schmidlin F."/>
<person name="Grady E.F."/>
<person name="Bunnett N.W."/>
</authorList>
<dbReference type="PubMed" id="15708858"/>
<dbReference type="DOI" id="10.1074/jbc.m500109200"/>
</citation>
<scope>UBIQUITINATION BY CBL</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="J. Thromb. Haemost." volume="3" first="2798" last="2805">
<title>Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.</title>
<authorList>
<person name="Feistritzer C."/>
<person name="Lenta R."/>
<person name="Riewald M."/>
</authorList>
<dbReference type="PubMed" id="16359518"/>
<dbReference type="DOI" id="10.1111/j.1538-7836.2005.01610.x"/>
</citation>
<scope>FUNCTION IN ENDOTHELIAL BARRIER PROTECTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="8363" last="8368">
<title>A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.</title>
<authorList>
<person name="Hansen K.K."/>
<person name="Sherman P.M."/>
<person name="Cellars L."/>
<person name="Andrade-Gordon P."/>
<person name="Pan Z."/>
<person name="Baruch A."/>
<person name="Wallace J.L."/>
<person name="Hollenberg M.D."/>
<person name="Vergnolle N."/>
</authorList>
<dbReference type="PubMed" id="15919826"/>
<dbReference type="DOI" id="10.1073/pnas.0409535102"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN COLITIS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="J. Pharmacol. Sci." volume="98" first="99" last="102">
<title>Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice.</title>
<authorList>
<person name="Takizawa T."/>
<person name="Tamiya M."/>
<person name="Hara T."/>
<person name="Matsumoto J."/>
<person name="Saito N."/>
<person name="Kanke T."/>
<person name="Kawagoe J."/>
<person name="Hattori Y."/>
</authorList>
<dbReference type="PubMed" id="15879675"/>
<dbReference type="DOI" id="10.1254/jphs.scz050138"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN BRONCHIAL EOSINOPHILIC INFLAMMATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Am. J. Physiol." volume="291" first="L628" last="L635">
<title>PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists.</title>
<authorList>
<person name="Winter M.C."/>
<person name="Shasby S.S."/>
<person name="Ries D.R."/>
<person name="Shasby D.M."/>
</authorList>
<dbReference type="PubMed" id="16714334"/>
<dbReference type="DOI" id="10.1152/ajplung.00046.2006"/>
</citation>
<scope>FUNCTION IN EPITHELIAL BARRIER DISRUPTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Blood" volume="107" first="4440" last="4448">
<title>Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway.</title>
<authorList>
<person name="Csernok E."/>
<person name="Ai M."/>
<person name="Gross W.L."/>
<person name="Wicklein D."/>
<person name="Petersen A."/>
<person name="Lindner B."/>
<person name="Lamprecht P."/>
<person name="Holle J.U."/>
<person name="Hellmich B."/>
</authorList>
<dbReference type="PubMed" id="16478888"/>
<dbReference type="DOI" id="10.1182/blood-2005-05-1875"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY PRTN3</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="J. Exp. Med." volume="203" first="425" last="435">
<title>Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.</title>
<authorList>
<person name="Noorbakhsh F."/>
<person name="Tsutsui S."/>
<person name="Vergnolle N."/>
<person name="Boven L.A."/>
<person name="Shariat N."/>
<person name="Vodjgani M."/>
<person name="Warren K.G."/>
<person name="Andrade-Gordon P."/>
<person name="Hollenberg M.D."/>
<person name="Power C."/>
</authorList>
<dbReference type="PubMed" id="16476770"/>
<dbReference type="DOI" id="10.1084/jem.20052148"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="20634" last="20646">
<title>Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2.</title>
<authorList>
<person name="Zoudilova M."/>
<person name="Kumar P."/>
<person name="Ge L."/>
<person name="Wang P."/>
<person name="Bokoch G.M."/>
<person name="DeFea K.A."/>
</authorList>
<dbReference type="PubMed" id="17500066"/>
<dbReference type="DOI" id="10.1074/jbc.m701391200"/>
</citation>
<scope>FUNCTION IN ACTIN FILAMENT SEVERING</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="30246" last="30255">
<title>p24A, a type I transmembrane protein, controls ARF1-dependent resensitization of protease-activated receptor-2 by influence on receptor trafficking.</title>
<authorList>
<person name="Luo W."/>
<person name="Wang Y."/>
<person name="Reiser G."/>
</authorList>
<dbReference type="PubMed" id="17693410"/>
<dbReference type="DOI" id="10.1074/jbc.m703205200"/>
</citation>
<scope>INTERACTION WITH TMED2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="J. Immunol." volume="178" first="5237" last="5244">
<title>Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2.</title>
<authorList>
<person name="Chiu L.L."/>
<person name="Perng D.W."/>
<person name="Yu C.H."/>
<person name="Su S.N."/>
<person name="Chow L.P."/>
</authorList>
<dbReference type="PubMed" id="17404307"/>
<dbReference type="DOI" id="10.4049/jimmunol.178.8.5237"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY MOLD ALLERGENS</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Am. J. Respir. Cell Mol. Biol." volume="39" first="530" last="535">
<title>Chitinase activates protease-activated receptor-2 in human airway epithelial cells.</title>
<authorList>
<person name="Hong J.H."/>
<person name="Hong J.Y."/>
<person name="Park B."/>
<person name="Lee S.I."/>
<person name="Seo J.T."/>
<person name="Kim K.E."/>
<person name="Sohn M.H."/>
<person name="Shin D.M."/>
</authorList>
<dbReference type="PubMed" id="18474671"/>
<dbReference type="DOI" id="10.1165/rcmb.2007-0410oc"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY BACTERIAL CHITINASE</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="1267" last="1274">
<title>G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NFkappaB serine 536 phosphorylation in human keratinocytes.</title>
<authorList>
<person name="Goon Goh F."/>
<person name="Sloss C.M."/>
<person name="Cunningham M.R."/>
<person name="Nilsson M."/>
<person name="Cadalbert L."/>
<person name="Plevin R."/>
</authorList>
<dbReference type="PubMed" id="18424071"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.02.015"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="24314" last="24325">
<title>Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity.</title>
<authorList>
<person name="Rallabhandi P."/>
<person name="Nhu Q.M."/>
<person name="Toshchakov V.Y."/>
<person name="Piao W."/>
<person name="Medvedev A.E."/>
<person name="Hollenberg M.D."/>
<person name="Fasano A."/>
<person name="Vogel S.N."/>
</authorList>
<dbReference type="PubMed" id="18622013"/>
<dbReference type="DOI" id="10.1074/jbc.m804800200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TLR4</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="6903" last="6910">
<title>Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection.</title>
<authorList>
<person name="Feld M."/>
<person name="Shpacovitch V.M."/>
<person name="Ehrhardt C."/>
<person name="Kerkhoff C."/>
<person name="Hollenberg M.D."/>
<person name="Vergnolle N."/>
<person name="Ludwig S."/>
<person name="Steinhoff M."/>
</authorList>
<dbReference type="PubMed" id="18453611"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.10.6903"/>
</citation>
<scope>FUNCTION IN ANTIVIRAL RESPONSE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28453" last="28466">
<title>Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2.</title>
<authorList>
<person name="Hasdemir B."/>
<person name="Murphy J.E."/>
<person name="Cottrell G.S."/>
<person name="Bunnett N.W."/>
</authorList>
<dbReference type="PubMed" id="19684015"/>
<dbReference type="DOI" id="10.1074/jbc.m109.025692"/>
</citation>
<scope>DEUBIQUITINATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="34444" last="34457">
<title>Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization.</title>
<authorList>
<person name="Ricks T.K."/>
<person name="Trejo J."/>
</authorList>
<dbReference type="PubMed" id="19815543"/>
<dbReference type="DOI" id="10.1074/jbc.m109.048942"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="J. Immunol." volume="182" first="7795" last="7802">
<title>Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway.</title>
<authorList>
<person name="Khoufache K."/>
<person name="LeBouder F."/>
<person name="Morello E."/>
<person name="Laurent F."/>
<person name="Riffault S."/>
<person name="Andrade-Gordon P."/>
<person name="Boullier S."/>
<person name="Rousset P."/>
<person name="Vergnolle N."/>
<person name="Riteau B."/>
</authorList>
<dbReference type="PubMed" id="19494303"/>
<dbReference type="DOI" id="10.4049/jimmunol.0803743"/>
</citation>
<scope>FUNCTION IN ANTIVIRAL RESPONSE</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="J. Immunol." volume="183" first="6708" last="6716">
<title>Recognition of fungal protease activities induces cellular activation and eosinophil-derived neurotoxin release in human eosinophils.</title>
<authorList>
<person name="Matsuwaki Y."/>
<person name="Wada K."/>
<person name="White T.A."/>
<person name="Benson L.M."/>
<person name="Charlesworth M.C."/>
<person name="Checkel J.L."/>
<person name="Inoue Y."/>
<person name="Hotta K."/>
<person name="Ponikau J.U."/>
<person name="Lawrence C.B."/>
<person name="Kita H."/>
</authorList>
<dbReference type="PubMed" id="19864598"/>
<dbReference type="DOI" id="10.4049/jimmunol.0901220"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVATION BY TRYPSIN AND FUNGAL ASPARTATE PROTEASE</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Ann. Rheum. Dis." volume="69" first="2051" last="2054">
<title>Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis.</title>
<authorList>
<person name="Ferrell W.R."/>
<person name="Kelso E.B."/>
<person name="Lockhart J.C."/>
<person name="Plevin R."/>
<person name="McInnes I.B."/>
</authorList>
<dbReference type="PubMed" id="20584806"/>
<dbReference type="DOI" id="10.1136/ard.2010.130336"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN ARTHRITIS</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Cell. Signal." volume="22" first="265" last="273">
<title>Proteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - a novel paradigm for G(q/11) linked GPCRs.</title>
<authorList>
<person name="McIntosh K."/>
<person name="Cunningham M.R."/>
<person name="Cadalbert L."/>
<person name="Lockhart J."/>
<person name="Boyd G."/>
<person name="Ferrell W.R."/>
<person name="Plevin R."/>
</authorList>
<dbReference type="PubMed" id="19781631"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.09.028"/>
</citation>
<scope>FUNCTION IN JNK PATHWAY</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="34803" last="34812">
<title>Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1.</title>
<authorList>
<person name="Bae J.S."/>
<person name="Yang L."/>
<person name="Rezaie A.R."/>
</authorList>
<dbReference type="PubMed" id="20826780"/>
<dbReference type="DOI" id="10.1074/jbc.m110.163642"/>
</citation>
<scope>FUNCTION IN ENDOTHELIAL BARRIER PROTECTION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2010" name="J. Dent. Res." volume="89" first="948" last="953">
<title>Protease-activated receptor-2 (PAR(2)) in human periodontitis.</title>
<authorList>
<person name="Holzhausen M."/>
<person name="Cortelli J.R."/>
<person name="da Silva V.A."/>
<person name="Franco G.C."/>
<person name="Cortelli S.C."/>
<person name="Vergnolle N."/>
</authorList>
<dbReference type="PubMed" id="20530726"/>
<dbReference type="DOI" id="10.1177/0022034510373765"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN PERIODONTITIS</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="Mucosal Immunol." volume="3" first="29" last="39">
<title>Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo.</title>
<authorList>
<person name="Nhu Q.M."/>
<person name="Shirey K."/>
<person name="Teijaro J.R."/>
<person name="Farber D.L."/>
<person name="Netzel-Arnett S."/>
<person name="Antalis T.M."/>
<person name="Fasano A."/>
<person name="Vogel S.N."/>
</authorList>
<dbReference type="PubMed" id="19865078"/>
<dbReference type="DOI" id="10.1038/mi.2009.120"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Immunology" volume="133" first="329" last="339">
<title>Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-gamma on human neutrophils and monocytes.</title>
<authorList>
<person name="Shpacovitch V.M."/>
<person name="Feld M."/>
<person name="Holzinger D."/>
<person name="Kido M."/>
<person name="Hollenberg M.D."/>
<person name="Levi-Schaffer F."/>
<person name="Vergnolle N."/>
<person name="Ludwig S."/>
<person name="Roth J."/>
<person name="Luger T."/>
<person name="Steinhoff M."/>
</authorList>
<dbReference type="PubMed" id="21501162"/>
<dbReference type="DOI" id="10.1111/j.1365-2567.2011.03443.x"/>
</citation>
<scope>FUNCTION IN ANTIMICROBIAL RESPONSE</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="Biochem. J." volume="438" first="359" last="367">
<title>Palmitoylation of human proteinase-activated receptor-2 differentially regulates receptor triggered ERK1/2 activation, calcium signalling, and endocytosis.</title>
<authorList>
<person name="Botham A."/>
<person name="Guo X."/>
<person name="Xiao Y.P."/>
<person name="Morice A.H."/>
<person name="Compton S.J."/>
<person name="Sadofsky L.R."/>
</authorList>
<dbReference type="PubMed" id="21627585"/>
<dbReference type="DOI" id="10.1042/bj20101958"/>
</citation>
<scope>PALMITOYLATION AT CYS-361</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="Arterioscler. Thromb. Vasc. Biol." volume="33" first="275" last="284">
<title>Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function.</title>
<authorList>
<person name="Kuckleburg C.J."/>
<person name="Newman P.J."/>
</authorList>
<dbReference type="PubMed" id="23202369"/>
<dbReference type="DOI" id="10.1161/atvbaha.112.300474"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PROTEOLYTIC CLEAVAGE</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2017" name="Nature" volume="545" first="112" last="115">
<title>Structural insight into allosteric modulation of protease-activated receptor 2.</title>
<authorList>
<person name="Cheng R.K.Y."/>
<person name="Fiez-Vandal C."/>
<person name="Schlenker O."/>
<person name="Edman K."/>
<person name="Aggeler B."/>
<person name="Brown D.G."/>
<person name="Brown G.A."/>
<person name="Cooke R.M."/>
<person name="Dumelin C.E."/>
<person name="Dore A.S."/>
<person name="Geschwindner S."/>
<person name="Grebner C."/>
<person name="Hermansson N.O."/>
<person name="Jazayeri A."/>
<person name="Johansson P."/>
<person name="Leong L."/>
<person name="Prihandoko R."/>
<person name="Rappas M."/>
<person name="Soutter H."/>
<person name="Snijder A."/>
<person name="Sundstrom L."/>
<person name="Tehan B."/>
<person name="Thornton P."/>
<person name="Troast D."/>
<person name="Wiggin G."/>
<person name="Zhukov A."/>
<person name="Marshall F.H."/>
<person name="Dekker N."/>
</authorList>
<dbReference type="PubMed" id="28445455"/>
<dbReference type="DOI" id="10.1038/nature22309"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 59-269 AND 276-377</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BOND</scope>
<scope>TOPOLOGY</scope>
<scope>MUTAGENESIS OF HIS-135; PHE-154; GLY-157; TYR-210; ASN-222; HIS-227; ASP-228 AND ILE-327</scope>
</reference>
<comment type="function">
<text evidence="7 8 11 12 13 14 17 19 20 21 22 23 24 25 26 27 28 29 30 31 33 34 35 36 38 39">Receptor for trypsin and trypsin-like enzymes coupled to G proteins (PubMed:28445455). Its function is mediated through the activation of several signaling pathways including phospholipase C (PLC), intracellular calcium, mitogen-activated protein kinase (MAPK), I-kappaB kinase/NF-kappaB and Rho (PubMed:28445455). Can also be transactivated by cleaved F2R/PAR1. Involved in modulation of inflammatory responses and regulation of innate and adaptive immunity, and acts as a sensor for proteolytic enzymes generated during infection. Generally is promoting inflammation. Can signal synergistically with TLR4 and probably TLR2 in inflammatory responses and modulates TLR3 signaling. Has a protective role in establishing the endothelial barrier; the activity involves coagulation factor X. Regulates endothelial cell barrier integrity during neutrophil extravasation, probably following proteolytic cleavage by PRTN3 (PubMed:23202369). Proposed to have a bronchoprotective role in airway epithelium, but also shown to compromise the airway epithelial barrier by interrupting E-cadherin adhesion (PubMed:10086357). Involved in the regulation of vascular tone; activation results in hypotension presumably mediated by vasodilation. Associates with a subset of G proteins alpha subunits such as GNAQ, GNA11, GNA14, GNA12 and GNA13, but probably not with G(o) alpha, G(i) subunit alpha-1 and G(i) subunit alpha-2. However, according to PubMed:21627585 can signal through G(i) subunit alpha. Believed to be a class B receptor which internalizes as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptor, for extended periods of time. Mediates inhibition of TNF-alpha stimulated JNK phosphorylation via coupling to GNAQ and GNA11; the function involves dissociation of RIPK1 and TRADD from TNFR1. Mediates phosphorylation of nuclear factor NF-kappa-B RELA subunit at 'Ser-536'; the function involves IKBKB and is predominantly independent of G proteins. Involved in cellular migration. Involved in cytoskeletal rearrangement and chemotaxis through beta-arrestin-promoted scaffolds; the function is independent of GNAQ and GNA11 and involves promotion of cofilin dephosphorylation and actin filament severing. Induces redistribution of COPS5 from the plasma membrane to the cytosol and activation of the JNK cascade is mediated by COPS5. Involved in the recruitment of leukocytes to the sites of inflammation and is the major PAR receptor capable of modulating eosinophil function such as proinflammatory cytokine secretion, superoxide production and degranulation. During inflammation promotes dendritic cell maturation, trafficking to the lymph nodes and subsequent T-cell activation. Involved in antimicrobial response of innate immune cells; activation enhances phagocytosis of Gram-positive and killing of Gram-negative bacteria. Acts synergistically with interferon-gamma in enhancing antiviral responses. Implicated in a number of acute and chronic inflammatory diseases such as of the joints, lungs, brain, gastrointestinal tract, periodontium, skin, and vascular systems, and in autoimmune disorders.</text>
</comment>
<comment type="subunit">
<text evidence="4">Interacts with TLR4, COPS5 and TMED2. Interacts with GNAQ, GNA11, GNA12, GNA13 and GNA14 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-4303019">
<id>P29066</id>
<label>Arrb1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-358933">
<id>P16615</id>
<label>ATP2A2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-594661">
<id>Q92905</id>
<label>COPS5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-4309771">
<id>Q14868</id>
<label>EPR-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-1040727">
<id>P13726</id>
<label>F3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-14100688">
<id>P0DMV9</id>
<label>HSPA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-977302">
<id>P04156</id>
<label>PRNP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4303189">
<id>P55085</id>
</interactant>
<interactant intactId="EBI-998485">
<id>Q15363</id>
<label>TMED2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="38 40 41">Widely expressed in tissues with especially high levels in pancreas, liver, kidney, small intestine, and colon (PubMed:7556175, PubMed:8615752). Moderate expression is detected in many organs, but none in brain or skeletal muscle (PubMed:7556175, PubMed:8615752). Expressed in endothelial cells (PubMed:23202369).</text>
</comment>
<comment type="PTM">
<text evidence="9 10 12 13 15 16 22 24 28 33 38 42">A proteolytic cleavage generates a new N-terminus that functions as a tethered ligand (PubMed:10831593, PubMed:19864598, PubMed:9020112, PubMed:10805786, PubMed:16478888). Activating serine proteases include trypsin, mast cell tryptase, coagulation factors VII and Xa, myeloblastin/PRTN3 and membrane-type serine protease 1/ST14 (PubMed:10831593, PubMed:19864598, PubMed:9020112, PubMed:10805786, PubMed:16478888, PubMed:23202369). Subsequent cleavage by serine proteases, including neutrophil elastase and cathepsin G, leads to receptor deactivation (PubMed:12594060). At least in part, implicated proteases are also shown to activate the receptor; the glycosylation status of the receptor is thought to contribute to the difference (PubMed:12171601). In addition to conventional trypsin-like proteases activated by other proteases and glycosidases derived from bacteria, fungi and insects (PubMed:11447194, PubMed:11441110, PubMed:17404307, PubMed:18474671, PubMed:19864598). Activated by serine protease allergens such as dust mite Der p3 and Der p9 and mold Pen c13 (PubMed:11441110, PubMed:17404307). Activated by P.gingivalis arginine-specific (trypsin-like) cysteine proteinases called gingipains (PubMed:11447194). Activated by S.griseus exogenous chitinase (PubMed:18474671). Activated by A.alternata aspartate protease; the cleavage generates non-conventional processed forms (PubMed:19864598).</text>
</comment>
<comment type="PTM">
<text evidence="15">N-glycosylated and sialylated.</text>
</comment>
<comment type="PTM">
<text evidence="32">Multiple phosphorylated on serine and threonine residues in the cytoplasmic region upon receptor activation; required for receptor desensitization and recruitment of beta-arrestin.</text>
</comment>
<comment type="PTM">
<text>Monoubiquitinated by CBL at the plasma membrane and in early endosomes; not required for receptor endocytosis but for translocation to late endosomes or lysosomes. Deubiquitination involves STAMBP and USP8; required for lysosomal trafficking and receptor degradation.</text>
</comment>
<comment type="miscellaneous">
<text>Synthetic PAR agonist peptides (APs) that mimic the first six amino acids of the newly formed N-terminus activate the native, uncleaved receptor nonenzymatically by binding directly to the corresponding second extracellular loop to mediate signaling.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the G-protein coupled receptor 1 family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Protease-activated_receptor"/>
<text>Protease-activated receptor entry</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/f2rl1/"/>
</comment>
<dbReference type="EMBL" id="Z49993">
<property type="protein sequence ID" value="CAA90290.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Z49994">
<property type="protein sequence ID" value="CAA90290.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U34038">
<property type="protein sequence ID" value="AAB47871.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY336105">
<property type="protein sequence ID" value="AAP97012.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF400075">
<property type="protein sequence ID" value="AAK77914.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT009856">
<property type="protein sequence ID" value="AAP88858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471084">
<property type="protein sequence ID" value="EAW95782.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012453">
<property type="protein sequence ID" value="AAH12453.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018130">
<property type="protein sequence ID" value="AAH18130.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U36753">
<property type="protein sequence ID" value="AAA90957.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4033.1"/>
<dbReference type="PIR" id="S66518">
<property type="entry name" value="S66518"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005233.3">
<property type="nucleotide sequence ID" value="NM_005242.5"/>
</dbReference>
<dbReference type="PDB" id="5NDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=59-269, A=276-377"/>
</dbReference>
<dbReference type="PDB" id="5NDZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A=59-269, A=276-377"/>
</dbReference>
<dbReference type="PDB" id="5NJ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A=55-269, A=276-377"/>
</dbReference>
<dbReference type="PDBsum" id="5NDD"/>
<dbReference type="PDBsum" id="5NDZ"/>
<dbReference type="PDBsum" id="5NJ6"/>
<dbReference type="SMR" id="P55085"/>
<dbReference type="BioGrid" id="108449">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="DIP" id="DIP-42044N"/>
<dbReference type="IntAct" id="P55085">
<property type="interactions" value="76"/>
</dbReference>
<dbReference type="MINT" id="P55085"/>
<dbReference type="STRING" id="9606.ENSP00000296677"/>
<dbReference type="BindingDB" id="P55085"/>
<dbReference type="ChEMBL" id="CHEMBL5963"/>
<dbReference type="GuidetoPHARMACOLOGY" id="348"/>
<dbReference type="TCDB" id="9.A.14.13.12">
<property type="family name" value="the g-protein-coupled receptor (gpcr) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P55085"/>
<dbReference type="PhosphoSitePlus" id="P55085"/>
<dbReference type="SwissPalm" id="P55085"/>
<dbReference type="BioMuta" id="F2RL1"/>
<dbReference type="DMDM" id="1709580"/>
<dbReference type="jPOST" id="P55085"/>
<dbReference type="MassIVE" id="P55085"/>
<dbReference type="MaxQB" id="P55085"/>
<dbReference type="PaxDb" id="P55085"/>
<dbReference type="PeptideAtlas" id="P55085"/>
<dbReference type="PRIDE" id="P55085"/>
<dbReference type="ProteomicsDB" id="56787"/>
<dbReference type="ABCD" id="P55085"/>
<dbReference type="Antibodypedia" id="4569">
<property type="antibodies" value="308 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2150"/>
<dbReference type="Ensembl" id="ENST00000296677">
<property type="protein sequence ID" value="ENSP00000296677"/>
<property type="gene ID" value="ENSG00000164251"/>
</dbReference>
<dbReference type="GeneID" id="2150"/>
<dbReference type="KEGG" id="hsa:2150"/>
<dbReference type="UCSC" id="uc003keo.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2150"/>
<dbReference type="DisGeNET" id="2150"/>
<dbReference type="GeneCards" id="F2RL1"/>
<dbReference type="HGNC" id="HGNC:3538">
<property type="gene designation" value="F2RL1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000164251">
<property type="expression patterns" value="Tissue enhanced (intestine)"/>
</dbReference>
<dbReference type="MIM" id="600933">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P55085"/>
<dbReference type="PharmGKB" id="PA27947"/>
<dbReference type="eggNOG" id="ENOG410IGEM">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111CWR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="CLU_009579_8_2_1"/>
<dbReference type="InParanoid" id="P55085"/>
<dbReference type="KO" id="K04234"/>
<dbReference type="OrthoDB" id="892946at2759"/>
<dbReference type="PhylomeDB" id="P55085"/>
<dbReference type="TreeFam" id="TF330775"/>
<dbReference type="Reactome" id="R-HSA-375276">
<property type="pathway name" value="Peptide ligand-binding receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416476">
<property type="pathway name" value="G alpha (q) signalling events"/>
</dbReference>
<dbReference type="SIGNOR" id="P55085"/>
<dbReference type="ChiTaRS" id="F2RL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Protease_activated_receptor_2"/>
<dbReference type="GenomeRNAi" id="2150"/>
<dbReference type="Pharos" id="P55085">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P55085"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P55085">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000164251">
<property type="expression patterns" value="Expressed in colonic mucosa and 172 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P55085">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P55085">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005623">
<property type="term" value="C:cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031143">
<property type="term" value="C:pseudopodium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004930">
<property type="term" value="F:G protein-coupled receptor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001965">
<property type="term" value="F:G-protein alpha-subunit binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031681">
<property type="term" value="F:G-protein beta-subunit binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:signaling receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0015057">
<property type="term" value="F:thrombin-activated receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045217">
<property type="term" value="P:cell-cell junction maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035926">
<property type="term" value="P:chemokine (C-C motif) ligand 2 secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090195">
<property type="term" value="P:chemokine secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061028">
<property type="term" value="P:establishment of endothelial barrier"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0072643">
<property type="term" value="P:interferon-gamma secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050702">
<property type="term" value="P:interleukin-1 beta secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072608">
<property type="term" value="P:interleukin-10 secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070661">
<property type="term" value="P:leukocyte proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097029">
<property type="term" value="P:mature conventional dendritic cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090198">
<property type="term" value="P:negative regulation of chemokine secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046329">
<property type="term" value="P:negative regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034140">
<property type="term" value="P:negative regulation of toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010804">
<property type="term" value="P:negative regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042119">
<property type="term" value="P:neutrophil activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030836">
<property type="term" value="P:positive regulation of actin filament depolymerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097755">
<property type="term" value="P:positive regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050921">
<property type="term" value="P:positive regulation of chemotaxis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002741">
<property type="term" value="P:positive regulation of cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051482">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043311">
<property type="term" value="P:positive regulation of eosinophil degranulation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003104">
<property type="term" value="P:positive regulation of glomerular filtration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000778">
<property type="term" value="P:positive regulation of interleukin-6 secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000484">
<property type="term" value="P:positive regulation of interleukin-8 secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002690">
<property type="term" value="P:positive regulation of leukocyte chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070963">
<property type="term" value="P:positive regulation of neutrophil mediated killing of gram-negative bacterium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060100">
<property type="term" value="P:positive regulation of phagocytosis, engulfment"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014068">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050927">
<property type="term" value="P:positive regulation of positive chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031274">
<property type="term" value="P:positive regulation of pseudopodium assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900135">
<property type="term" value="P:positive regulation of renin secretion into blood stream"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035025">
<property type="term" value="P:positive regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034137">
<property type="term" value="P:positive regulation of toll-like receptor 2 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034141">
<property type="term" value="P:positive regulation of toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034145">
<property type="term" value="P:positive regulation of toll-like receptor 4 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030193">
<property type="term" value="P:regulation of blood coagulation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043122">
<property type="term" value="P:regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046328">
<property type="term" value="P:regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002286">
<property type="term" value="P:T cell activation involved in immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000276">
<property type="entry name" value="GPCR_Rhodpsn"/>
</dbReference>
<dbReference type="InterPro" id="IPR017452">
<property type="entry name" value="GPCR_Rhodpsn_7TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR002281">
<property type="entry name" value="Pro_rcpt_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR003912">
<property type="entry name" value="Protea_act_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00001">
<property type="entry name" value="7tm_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00237">
<property type="entry name" value="GPCRRHODOPSN"/>
</dbReference>
<dbReference type="PRINTS" id="PR01428">
<property type="entry name" value="PROTEASEAR"/>
</dbReference>
<dbReference type="PRINTS" id="PR01152">
<property type="entry name" value="PROTEASEAR2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50262">
<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="5">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="propeptide" description="Removed for receptor activation" id="PRO_0000012750">
<location>
<begin position="26"/>
<end position="36"/>
</location>
</feature>
<feature type="chain" description="Proteinase-activated receptor 2" id="PRO_0000412954">
<location>
<begin position="37"/>
<end position="397"/>
</location>
</feature>
<feature type="chain" description="Proteinase-activated receptor 2, alternate cleaved 1" id="PRO_0000412956">
<location>
<begin position="38"/>
<end position="397"/>
</location>
</feature>
<feature type="chain" description="Proteinase-activated receptor 2, alternate cleaved 2" id="PRO_0000012751">
<location>
<begin position="39"/>
<end position="397"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="39">
<location>
<begin position="37"/>
<end position="71"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="39">
<location>
<begin position="72"/>
<end position="101"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="39">
<location>
<begin position="102"/>
<end position="108"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="39">
<location>
<begin position="109"/>
<end position="137"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="39">
<location>
<begin position="138"/>
<end position="149"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="39">
<location>
<begin position="150"/>
<end position="177"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="39">
<location>
<begin position="178"/>
<end position="183"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="39">
<location>
<begin position="184"/>
<end position="211"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="39">
<location>
<begin position="212"/>
<end position="235"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="39">
<location>
<begin position="236"/>
<end position="269"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="39">
<location>
<begin position="270"/>
<end position="277"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="39">
<location>
<begin position="278"/>
<end position="317"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="39">
<location>
<begin position="318"/>
<end position="323"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="39">
<location>
<begin position="324"/>
<end position="347"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="39">
<location>
<begin position="348"/>
<end position="397"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="383"/>
<end position="390"/>
</location>
</feature>
<feature type="site" description="Cleavage; by trypsin">
<location>
<begin position="36"/>
<end position="37"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="37">
<location>
<position position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="15">
<location>
<position position="30"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="15">
<location>
<position position="222"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 6 39">
<location>
<begin position="148"/>
<end position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2243072." id="VAR_012846" evidence="43">
<original>S</original>
<variation>F</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs616235." id="VAR_049435">
<original>N</original>
<variation>S</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2243062." id="VAR_012847" evidence="43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2243083." id="VAR_012848" evidence="43">
<original>T</original>
<variation>A</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases cell surface expression; when associate with A-222." evidence="15">
<original>N</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increase of sensitivity towards tryptase." evidence="15">
<original>N</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight reduction in ligand-mediated receptor activation." evidence="39">
<original>H</original>
<variation>Y</variation>
<location>
<position position="135"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe reduction in ligand-mediated receptor activation." evidence="39">
<original>F</original>
<variation>A</variation>
<location>
<position position="154"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe reduction in ligand-mediated receptor activation." evidence="39">
<original>G</original>
<variation>C</variation>
<variation>M</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ligand-mediated receptor activation." evidence="39">
<original>Y</original>
<variation>L</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases cell surface expression; when associated with A-30. Loss of sensitivity towards all tested proteases." evidence="15">
<original>N</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ligand-mediated receptor activation." evidence="39">
<original>N</original>
<variation>Q</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="No defect in ligand-mediated receptor activation." evidence="39">
<original>H</original>
<variation>A</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight reduction in ligand-mediated receptor activation." evidence="39">
<original>H</original>
<variation>Q</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe reduction in ligand-mediated receptor activation." evidence="39">
<original>D</original>
<variation>A</variation>
<variation>N</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight reduction in ligand-mediated receptor activation." evidence="39">
<original>I</original>
<variation>L</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes signaling through accumulation of intracellular calcium and phosphoinositide; no effect in signaling through MAPK." evidence="18">
<location>
<begin position="355"/>
<end position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of palmitoylation; increases surface expression and internalization following trypsin activation, decreases sensitivity and intracellular calcium signaling, increases ERK activation through G(i) subunit alpha.">
<original>C</original>
<variation>A</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces receptor desensitization and internalization, activates ERK1/2; when associated with A-366." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces receptor desensitization and internalization, activates ERK1/2; when associated with A-363." evidence="8">
<original>T</original>
<variation>A</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB47871." ref="2" evidence="44">
<original>G</original>
<variation>A</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH18130." ref="7" evidence="44">
<original>T</original>
<variation>S</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="63"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="72"/>
<end position="75"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="77"/>
<end position="102"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="109"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="128"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="145"/>
<end position="178"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="186"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="207"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="215"/>
<end position="218"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="219"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="223"/>
<end position="229"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="236"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="252"/>
<end position="269"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="279"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="301"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="323"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="336"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="358"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NDD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NDZ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NJ6"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00521"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10086357"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10725339"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805786"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10831593"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11413129"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11441110"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11447194"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11714832"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12171601"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12594060"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12832443"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14607272"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15155775"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16359518"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16410250"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16478888"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16714334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17404307"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17500066"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18424071"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18453611"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18474671"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18622013"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19494303"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19781631"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19815543"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19864598"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19865078"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20826780"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21501162"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21627585"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23202369"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28445455"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7556175"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8615752"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9020112"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<sequence length="397" mass="44126" checksum="F1A4E1D5AB9B362B" modified="1996-10-01" version="1" precursor="true">MRSPSAAWLLGAAILLAASLSCSGTIQGTNRSSKGRSLIGKVDGTSHVTGKGVTVETVFSVDEFSASVLTGKLTTVFLPIVYTIVFVVGLPSNGMALWVFLFRTKKKHPAVIYMANLALADLLSVIWFPLKIAYHIHGNNWIYGEALCNVLIGFFYGNMYCSILFMTCLSVQRYWVIVNPMGHSRKKANIAIGISLAIWLLILLVTIPLYVVKQTIFIPALNITTCHDVLPEQLLVGDMFNYFLSLAIGVFLFPAFLTASAYVLMIRMLRSSAMDENSEKKRKRAIKLIVTVLAMYLICFTPSNLLLVVHYFLIKSQGQSHVYALYIVALCLSTLNSCIDPFVYYFVSHDFRDHAKNALLCRSVRTVKQMQVSLTSKKHSRKSSSYSSSSTTVKTSY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>